Evidence map›Paper›PMID 38622623›Full record

ArticleWorld journal of surgical oncology2024

Extensive surgical resections for rare pleural neoplasms: a single-center experience with a yolk sac tumor and synovial sarcoma.

Tom Vandaele, Jan Van Slambrouck, Patrick Schöffski, Herlinde Dumez, Birgit Weynand, Raf Sciot, Annalisa Barbarossa, An-Lies Provoost, Kristof Van de Voorde, Yves Debaveye and 3 more

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of surgical oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Present and future of cytoreductive surgery and hyperthermic intrathoracic chemotherapy for pleural metastases: a narrative review.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Tom VandaeleDepartment of Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium. vandaeletom@live.be.
Jan Van SlambrouckDepartment of Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium.
Patrick SchöffskiDepartment of Oncology, University Hospitals Leuven, Leuven, Belgium.
Herlinde DumezDepartment of Oncology, University Hospitals Leuven, Leuven, Belgium.
Birgit WeynandDepartment of Pathology, University Hospitals Leuven, Leuven, Belgium.
Raf SciotDepartment of Pathology, University Hospitals Leuven, Leuven, Belgium.
Annalisa BarbarossaDepartment of Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium.
An-Lies ProvoostDepartment of Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium.
Kristof Van de VoordeDepartment of Perfusion, University Hospitals Leuven, Leuven, Belgium.
Yves DebaveyeDepartment of Intensive care, University Hospitals Leuven, Leuven, Belgium.
Sofian BounebDepartment of Anesthesiology, University Hospitals Leuven, Leuven, Belgium.
Philippe NafteuxDepartment of Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium.
Laurens J CeulemansDepartment of Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium.
KU Leuven · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPleural neoplasms are rare and can be subdivided into pleural metastasis and primary pleural neoplasms. Non-mesothelioma primary pleural neoplasms are a diverse group of extremely rare pathologies. CASE PRESENTATION: In this case series, we describe the presentation and management of two rare primary pleural neoplasms. A first case describes a primary pleural yolk sac tumor treated with neoadjuvant chemotherapy, extended pleurectomy decortication, and hyperthermic intrathoracic chemotherapy. In a second case we describe the management of a primary pleural synovial sarcoma by neoadjuvant chemotherapy and extrapleural pneumonectomy. A complete resection was obtained in both cases and the post-operative course was uncomplicated. No signs of tumor recurrence were noted during follow-up in the first patient. In the second patient a local recurrence was diagnosed 6 months after surgery.

conclusionNeo-adjuvant chemotherapy followed by extensive thoracic surgery, including hyperthermic intrathoracic chemotherapy, is a feasible treatment strategy for non-mesothelioma primary pleural neoplasms, but careful follow-up is required.

Indexed as

Endodermal Sinus TumorPleural NeoplasmsSarcoma, SynovialHumansNeoplasm Recurrence, LocalPneumonectomyTreatment OutcomeHyperthermic intrathoracic chemotherapyPleural synovial sarcomaPleural tumorPleural yolk sac tumor

Identifiers

PMID38622623
PMCPMC11021014
OpenAlexW4394850650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.